Calyx Welcomes Catalyst to the ACTIVATE CRO Partnership Program Synergistic offerings deliver successful early-phase oncology clinical trials. News provided by Share this article Share this article NOTTINGHAM, England, May 10, 2021 /PRNewswire/ -- Calyx, the eClinical and Regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that Catalyst Clinical Research will enter into a partnership with Calyx to leverage Calyx's Medical Imaging solution for their customers' oncology trials. John Blakeley, Chief Commercial Officer, Calyx Calyx's proven imaging services complement Catalyst's expertise in executing complex oncology trials for biotech clients A leading provider of clinical research services, Catalyst Clinical Research's full-service, niche oncology CRO solution is focused on next-generation cancer therapies. Catalyst Oncology offers skilled management of immuno-oncology and targeted therapies, as well as expert oversight of complex study designs to deliver customized clinical research solutions exclusively for the biotech market.